The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives
Open accessAbstract
Mitochondrial targeting is a promising approach for solving current issues in clinical application of chemotherapy and diagnosis of several disorders. Here, we discuss direct conjugation of mitochondrial-targeting moieties to anticancer drugs, antioxidants and sensor molecules. Among them, the most widely applied mitochondrial targeting moiety is triphenylphosphonium (TPP), which is a delocalized cationic lipid that readily accumulates and penetrates through the mitochondrial membrane due to the highly negative mitochondrial membrane potential. Other moieties, including short peptides, dequalinium, guanidine, rhodamine, and F16, are also known to be promising mitochondrial targeting agents. Direct conjugation of mitochondrial targeting moieties to anticancer drugs, antioxidants and sensors results in increased cytotoxicity, anti-oxidizing activity and sensing activity, respectively, compared with their non-targeting counterparts, especially in drug-resistant cells. Although many mitochondria-targeted anticancer drug conjugates have been investigated in vitro and in vivo , further clinical studies are still needed. On the other hand, several mitochondria-targeting antioxidants have been analyzed in clinical phases I, II and III trials, and one conjugate has been approved for treating eye disease in Russia. There are numerous ongoing studies of mitochondria-targeted sensors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lotito, S. B., & Frei, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.033 · Cited by 770
RetractedMitochondria targeting nano agents in cancer therapeutics
Zhang, X., & Zhang, P.-Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.5302 · Cited by 32
RetractedTargeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Mitochondrial DNA mutations in human disease
Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,852
Mitochondrial form and function
Friedman, J. R., & Nunnari, J. (2014) · Nature · doi:10.1038/nature12985 · Cited by 1,803
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Reactive oxygen species: role in the development of cancer and various chronic conditions.
Waris, G., & Ahsan, H. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-14 · Cited by 1,459
Mitochondrial Oxidative Stress: Implications for Cell Death
Orrenius, S., Gogvadze, V., & Zhivotovsky, B. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105122 · Cited by 1,272
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., & Dikalov, S. I. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 737
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
The fine structure of mitochondria
Palade, G. E. (1952) · The Anatomical Record · doi:10.1002/ar.1091140304 · Cited by 674
Mitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
Mitochondrial dysfunction and molecular pathways of disease
Pieczenik, S. R., & Neustadt, J. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.09.008 · Cited by 637
Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
Chipuk, J. E., Bouchier-Hayes, L., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401963 · Cited by 631
Mitochondria: a historical review.
Ernster, L., & Schatz, G. (1981) · The Journal of cell biology · doi:10.1083/jcb.91.3.227s · Cited by 628
Membrane potential and cancer progression
Yang, M., & Brackenbury, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00185 · Cited by 614
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
Modica-Napolitano, J. S., & Aprille, J. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00125-9 · Cited by 576
Chlorinative stress: An under appreciated mediator of neurodegeneration?
Yap, Y. W., Whiteman, M., & Cheung, N. S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.06.013 · Cited by 570
Baracca, A., Sgarbi, G., Solaini, G., & Lenaz, G. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(03)00110-5 · Cited by 565
Zeviani, M., & Spinazzola, A. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0026-9 · Cited by 533
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Costantini, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1042 · Cited by 532
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524
Mechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria
LIBERMAN, E. A., TOPALY, V. P., TSOFINA, L. M., JASAITIS, A. A., & SKULACHEV, V. P. (1969) · Nature · doi:10.1038/2221076a0 · Cited by 489
Mitochondria-Penetrating Peptides
Horton, K. L., Stewart, K. M., Fonseca, S. B., Guo, Q., & Kelley, S. O. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.015 · Cited by 465
Mitochondria‐targeted antioxidants
Oyewole, A. O., & Birch‐Machin, M. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-275404 · Cited by 464
Hu, Q., Gao, M., Feng, G., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408897 · Cited by 419
The molecular machinery of Keilin's respiratory chain
Rich, P. R. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311095 · Cited by 408
Zeviani, M. (2004) · Brain · doi:10.1093/brain/awh259 · Cited by 388
Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling
Jain, M., Rivera, S., Monclus, E. A., Synenki, L., Zirk, A., Eisenbart, J., Feghali-Bostwick, C., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431973 · Cited by 381
Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02250.x · Cited by 379
Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A. J., Cochemé, H. M., Murphy, M. P., & Dominiczak, A. F. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130351 · Cited by 367
Selective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330
Antonenko, Y. N., Avetisyan, A. V., Bakeeva, L. E., Chernyak, B. V., Chertkov, V. A., Domnina, L. V., Ivanova, O. Y., Izyumov, D. S., Khailova, L. S., Klishin, S. S., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120018 · Cited by 326
Cell-permeable, mitochondrial-targeted, peptide antioxidants
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1007/bf02854898 · Cited by 316
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Mitochondrial dysfunction in cancer
Modica-Napolitano, J. S., & Singh, K. K. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.027 · Cited by 299
Xu, J., Pan, J., Jiang, X., Qin, C., Zeng, L., Zhang, H., & Zhang, J. F. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.10.049 · Cited by 278
Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
Cheng, G., Zielonka, J., Dranka, B. P., McAllister, D., Mackinnon, A. C., Joseph, J., & Kalyanaraman, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3928 · Cited by 263
Lowes, D. A., Thottakam, B. M. V., Webster, N. R., Murphy, M. P., & Galley, H. F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.003 · Cited by 261
Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., & Chen, L. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5444 · Cited by 240
Kang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth
Fantin, V. R., Berardi, M. J., Scorrano, L., Korsmeyer, S. J., & Leder, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00082-x · Cited by 228
Methods for the assessment of mitochondrial membrane permeabilization in apoptosis
Galluzzi, L., Zamzami, N., de La Motte Rouge, T., Lemaire, C., Brenner, C., & Kroemer, G. (2007) · Apoptosis · doi:10.1007/s10495-007-0720-1 · Cited by 224
Rodriguez-Cuenca, S., Cochemé, H. M., Logan, A., Abakumova, I., Prime, T. A., Rose, C., Vidal-Puig, A., Smith, A. C., Rubinsztein, D. C., Fearnley, I. M., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.039 · Cited by 218
Dashdorj, A., KR, J., Lim, S., Jo, A., Nguyen, M. N., Ha, J., Yoon, K.-S., Kim, H. J., Park, J.-H., Murphy, M. P., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-178 · Cited by 205
Targeting Cancer Cell Mitochondria as a Therapeutic Approach
Wen, S., Zhu, D., & Huang, P. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.190 · Cited by 200
Targeted Delivery of Doxorubicin to Mitochondria
Chamberlain, G. R., Tulumello, D. V., & Kelley, S. O. (2013) · ACS Chemical Biology · doi:10.1021/cb400095v · Cited by 198
DQAsomes: A Novel Potential Drug and Gene Delivery System Made from Dequalinium™
Weissig, V., Lasch, J., Erdos, G., Meyer, H. W., Rowe, T. C., & Hughes, J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011991307631 · Cited by 193
Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
Ghosh, A., Chandran, K., Kalivendi, S. V., Joseph, J., Antholine, W. E., Hillard, C. J., Kanthasamy, A., Kanthasamy, A., & Kalyanaraman, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.028 · Cited by 190
Skulachev, V. P. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907120139 · Cited by 190
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Wisnovsky, S. P., Wilson, J. J., Radford, R. J., Pereira, M. P., Chan, M. R., Laposa, R. R., Lippard, S. J., & Kelley, S. O. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.08.010 · Cited by 185
Millard, M., Gallagher, J. D., Olenyuk, B. Z., & Neamati, N. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012438 · Cited by 160
Targeting drugs to mitochondria
Heller, A., Brockhoff, G., & Göpferich, A. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.05.014 · Cited by 158
Wang, Z., Guo, W., Kuang, X., Hou, S., & Liu, H. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.05.006 · Cited by 156
Solesio, M. E., Prime, T. A., Logan, A., Murphy, M. P., Jiménez, M. D. M. A., Jordán, J., & Galindo, M. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.009 · Cited by 153
Antioxidants as therapies: can we improve on nature?
Murphy, M. P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.010 · Cited by 151
Miquel, E., Cassina, A., Palma, L. M., Souza, J. M., Bolatto, C., Rodríguez-Bottero, S., Logan, A., Smith, R. A. J., Murphy, M. P., Barbeito, L., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.019 · Cited by 148
Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis
Galley, H. F. (2010) · Critical Care · doi:10.1186/cc9098 · Cited by 148
Small mitochondria-targeting molecules as anti-cancer agents
Wang, F., Ogasawara, M. A., & Huang, P. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.003 · Cited by 143
Wu, X., Sun, S., Wang, Y., Zhu, J., Jiang, K., Leng, Y., Shu, Q., & Lin, H. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.10.060 · Cited by 142
Cheng, G., Zielonka, J., McAllister, D. M., Mackinnon, A. C., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-285 · Cited by 135
Polyphenols as mitochondria-targeted anticancer drugs
Gorlach, S., Fichna, J., & Lewandowska, U. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.004 · Cited by 134
Crane, F. L. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.002255 · Cited by 133
Synthesis and Characterization of a Triphenylphosphonium-conjugated Peroxidase Mimetic
Filipovska, A., Kelso, G. F., Brown, S. E., Beer, S. M., Smith, R. A. J., & Murphy, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501148200 · Cited by 130
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
Millard, M., Pathania, D., Shabaik, Y., Taheri, L., Deng, J., & Neamati, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013131 · Cited by 129
Li, K., Hou, J., Yang, J. P., & Yu, X. (2017) · Chemical Communications · doi:10.1039/c7cc01679d · Cited by 129
Rerouting Chlorambucil to Mitochondria Combats Drug Deactivation and Resistance in Cancer Cells
Fonseca, S. B., Pereira, M. P., Mourtada, R., Gronda, M., Horton, K. L., Hurren, R., Minden, M. D., Schimmer, A. D., & Kelley, S. O. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.02.010 · Cited by 124
Approaches for targeting mitochondria in cancer therapy
D’Souza, G. G. M., Wagle, M. A., Saxena, V., & Shah, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.008 · Cited by 121
Burns, R. J., Smith, R. A. J., & Murphy, M. P. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1436 · Cited by 114
Dong, L., Jameson, V. J. A., Tilly, D., Procházka, L., Rohlena, J., Vališ, K., Truksa, J., Zobalová, R., Mahdavian, E., Kľučková, K., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.032 · Cited by 106
Scarano, W., Duong, H. T. T., Lu, H., de Souza, P. L., & Stenzel, M. H. (2013) · Biomacromolecules · doi:10.1021/bm400121q · Cited by 105
Opening and closing the metabolite gate
Törnroth‐Horsefield, S., & Neutze, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810654106 · Cited by 103
Chen, W., Xu, X., Luo, G., Jia, H.-Z., Lei, Q., Cheng, S., Zhuo, R., & Zhang, X. (2013) · Scientific Reports · doi:10.1038/srep03468 · Cited by 99
Derivatives of Rhodamine 19 as Mild Mitochondria-targeted Cationic Uncouplers
Antonenko, Y. N., Avetisyan, A. V., Cherepanov, D. A., Кнорре, Д. А., Korshunova, G. A., Маркова, О. В., Ojovan, S. M., Perevoshchikova, I. V., Pustovidko, A. V., Rokitskaya, T. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212837 · Cited by 99
Mitochondria Targeting by Guanidine− and Biguanidine−Porphyrin Photosensitizers
Sibrian‐Vazquez, M., Nesterova, I. V., Jensen, T. J., & Vicente, M. G. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700393u · Cited by 97
Mitochondrial Aβ A potential cause of metabolic dysfunction in Alzheimer's disease
Chen, X., & Yan, S. D. (2006) · IUBMB Life · doi:10.1080/15216540601047767 · Cited by 96
Buondonno, I., Gazzano, E., Jean, S. R., Audrito, V., Kopecka, J., Fanelli, M., Salaroglio, I. C., Costamagna, C., Roato, I., Mungo, E., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0048 · Cited by 94
Cho, D. Y., Cho, H., Kwon, K., Yu, M., Lee, E. J., Huh, K. M., Lee, D. H., & Kang, H. C. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501422 · Cited by 93
Self-citationPhotodynamic Tumor Therapy: Mitochondrial Benzodiazepine Receptors as a Therapeutic Target
Verma, A. M., Facchina, S. L., Hirsch, D. B., Song, S.-Y., Dillahey, L. F., Williams, J. R., & Snyder, S. H. (1998) · Molecular Medicine · doi:10.1007/bf03401728 · Cited by 92
Oyewole, A. O., Wilmot, M., Fowler, M., & Birch‐Machin, M. A. (2014) · The FASEB Journal · doi:10.1096/fj.13-237008 · Cited by 90
A novel bifunctional mitochondria-targeted anticancer agent with high selectivity for cancer cells
He, H., Li, D.-W., Yang, L., Fu, L., Zhu, X., Wong, W., Jiang, F., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep13543 · Cited by 82
Cheng, G., Zielonka, J., McAllister, D. M., Hardy, M., Ouari, O., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.016 · Cited by 82
Brown, S. E., Ross, M. F., Sanjuán-Pla, A., Manas, A. B., Smith, R. A. J., & Murphy, M. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.033 · Cited by 81
Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis.
Lampidis, T. J., Hasin, Y., Weiss, M. J., & Chen, L. B. (1985) · PubMed · Cited by 79
Jiang, J., Stoyanovsky, D. A., Belikova, N. A., Tyurina, Y. Y., Zhao, Q., Tungekar, M. A., Kapralova, V. I., Huang, Z., Mintz, A. H., Greenberger, J. S., et al. (2009) · Radiation Research · doi:10.1667/rr1729.1 · Cited by 76
Chegaev, K. Y., Riganti, C., Lazzarato, L., Rolando, B., Guglielmo, S., Campia, I., Fruttero, R., Bosìa, A., & Gasco, A. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100302t · Cited by 75
Mitochondrial-Targeting Nitrooxy-doxorubicin: A New Approach To Overcome Drug Resistance
Riganti, C., Rolando, B., Kopecka, J., Campia, I., Chegaev, K. Y., Lazzarato, L., Federico, A., Fruttero, R., & Ghigo, D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300311b · Cited by 74
Zhang, S., Yang, L., Ling, X., Shao, P., Wang, X., Edwards, W. B., & Bai, M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.033 · Cited by 74
Stucki, D., Ruegsegger, C., Steiner, S., Radecke, J., Murphy, M. P., Zuber, B., & Saxena, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.005 · Cited by 73
Lei, W., Xie, J., Hou, Y., Jiang, G., Zhang, H., Wang, P., Wang, X., & Zhang, B. (2009) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2009.12.003 · Cited by 70
Xu, S., Luo, S., Yao, H., Cai, H., Miao, X., Wu, F., Yang, D., Wu, X., Xie, W., Yao, H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00408 · Cited by 70
Tian, J., Chen, H., Zhuo, L., Xie, Y., Li, N., & Tang, B. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201100148 · Cited by 69
Cell-Permeable Iminocoumarine-Based Fluorescent Dyes for Mitochondria
Guo, D., Chen, T., Ye, D., Xu, J., Jiang, H., Chen, K., Wang, H., & Liu, H. (2011) · Organic Letters · doi:10.1021/ol200908r · Cited by 68
Membrane potential mediates the cellular binding of nanoparticles
Shin, E. H., Li, Y., Kumar, U., Sureka, H. V., Zhang, X., & Payne, C. K. (2013) · Nanoscale · doi:10.1039/c3nr01667f · Cited by 62
A Mitochondria-Targeted Macrocyclic Mn(II) Superoxide Dismutase Mimetic
Kelso, G. F., Maroz, A., Cochemé, H. M., Logan, A., Prime, T. A., Peskin, A. V., Winterbourn, C. C., James, A. M., Ross, M. F., Brooker, S., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.005 · Cited by 62
Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue
Dairkee, S. H., & Hackett, A. J. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01975444 · Cited by 59
A mitochondria-targeted derivative of ascorbate: MitoC
Finichiu, P. G., Larsen, D. S., Evans, C., Larsen, L., Bright, T. P., Robb, E. L., Trnka, J., Prime, T. A., James, A. M., Smith, R. A. J., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.160 · Cited by 59
THE ORGANIZATION OF LIVING MATTER
Palade, G. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.52.2.613 · Cited by 58
Design, synthesis and biological evaluation of mitochondria targeting theranostic agents
Wu, S., Cao, Q., Wang, X., Cheng, K., & Cheng, Z. (2014) · Chemical Communications · doi:10.1039/c4cc03296a · Cited by 51
Starenki, D., & Park, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3671 · Cited by 49
Song, Y., Liu, D., Cheng, Y., Liu, M., Ye, W., Zhang, B., Liu, X.-Y., & Zhou, S. (2015) · Scientific Reports · doi:10.1038/srep16125 · Cited by 49
Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants
Jameson, V. J. A., Cochemé, H. M., Logan, A., Hanton, L. R., Smith, R. A. J., & Murphy, M. P. (2015) · Tetrahedron · doi:10.1016/j.tet.2015.09.014 · Cited by 47
Battogtokh, G., & Ko, Y. T. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.014 · Cited by 47
Self-citationRe-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism
Mourtada, R., Fonseca, S. B., Wisnovsky, S., Pereira, M. P., Wang, X., Hurren, R., Parfitt, J. R., Larsen, L., Smith, R. A. J., Murphy, M. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060253 · Cited by 42
Christman, J. E., Miller, D. S., Coward, P., Smith, L. H., & Teng, N. N. H. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90402-7 · Cited by 41
Huang, H., Liu, W., Liu, X., Kuang, Y., & Jiang, J. (2017) · Talanta · doi:10.1016/j.talanta.2017.03.043 · Cited by 37
Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity
Cortes, L. A., Castro, L., Pesce, B., Maya, J. D., Ferreira, J., Castro-Castillo, V., Parra, E., Jara, J. A., & López‐Muñoz, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136852 · Cited by 36
Mitochondria-Targeted Spin Traps: Synthesis, Superoxide Spin Trapping, and Mitochondrial Uptake
Hardy, M., Poulhès, F., Rizzato, E., Rockenbauer, A., Banaszak, K., Karoui, H., López, M., Zielonka, J., Vasquez-Vivar, J. M., Sethumadhavan, S., et al. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500032e · Cited by 36
Wang, H., & Xu, W. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.116 · Cited by 31
Guo, T., Zhu, Y., Gan, C. S., Lee, S. S., Zhu, J., Wang, H., Li, X., Christensen, J. G., Huang, S., Kon, O. L., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001776 · Cited by 30
Antihypertensive effect of mitochondria-targeted proxyl nitroxides
Dikalova, A., Kirilyuk, I. A., & Dikalov, S. (2014) · Redox Biology · doi:10.1016/j.redox.2014.12.012 · Cited by 30
Wang, J., Fan, X., Yang, L., He, H., Huang, R., Jiang, F., & Liu, Y. (2016) · MedChemComm · doi:10.1039/c6md00268d · Cited by 30
Peptide-Chlorambucil Conjugates Combat Pgp-Dependent Drug Efflux
Fonseca, S. B., & Kelley, S. O. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1002663 · Cited by 23
Kim, K. H., Park, J. Y., Jung, H. J., & Kwon, H. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.022 · Cited by 21
Choi, Y. S., Kwon, K., Yoon, K., Huh, K. M., & Kang, H. C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.013 · Cited by 18
Self-citationMoon, S. Y., Choi, Y. S., Cho, J., Yu, M., Lee, E. J., Huh, K. M., Lee, D. H., Kim, J.-H., & Kang, H. C. (2016) · RSC Advances · doi:10.1039/c5ra25319e · Cited by 15
Self-citationMitochondrial-Targeting MET Kinase Inhibitor Kills Erlotinib-Resistant Lung Cancer Cells
Yang, T., Ng, W. H., Chen, H., Chomchopbun, K., Huynh, T. H., Go, M., & Kon, O. L. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00223 · Cited by 13
Maddalena, L. A., Ghelfi, M. D., Atkinson, J., & Stuart, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.11.005 · Cited by 13
Cited by
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Guo, X., Yang, N., Ji, W., Zhang, H., Dong, X., Zhou, Z., Li, L., Shen, H., Yao, S. Q., & Huang, W. (2021) · Advanced Materials · doi:10.1002/adma.202007778 · Cited by 421
Hu, C., Zhang, X., Wei, W., Zhang, N., Wu, H., Ma, Z., Li, L., Deng, W., & Tang, Q. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.003 · Cited by 261
Metadata
- Authors
- Battogtokh, G., Choi, Y. S., Kang, D. S., Park, S. J., Shim, M. S., Huh, K. M., Cho, Y.-Y., Lee, J. Y., Lee, H. S., & Kang, H. C.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 8
- Issue
- 6
- Pages
- 862-880
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2803687733
- Cited by
- 310
- References
- 130
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.